Skip to main content

DNLI

Denali Therapeutics Inc.

Company with tickers: DNLI

CIK
1714899
CUSIP
24823R105
Shares Outstanding
158,709,737
13F Activity (30d)
146 filings 145 filers

Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.

Filed Type Offering Sold
2024-03-01 New $499,732,711 $499,732,711
Showing 1–1 of 1 filings